NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
•
Jan 14, 2021, 12:19 PM
•
Updated 1,437 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
103ds ago
Hometown Heroes in the Hudson Valley
150ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
294ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
315ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
442ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
443ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
103ds agoHometown Heroes in the Hudson Valley
150ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
294ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
315ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
442ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
443ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
More from News 12
1:40
STORM WATCH: Deep cold with wind and partly sunny skies in the Hudson Valley
2:20
Thunderbolt 12: Driving conditions after the first snowfall in Westchester
0:25
Police: Dutchess County drug dealer behind bars
0:25
Police: Porch pirates arrested in connection with package larcenies in Poughkeepsie
1:28
FDA announces new criteria for what foods can be considered healthy
0:31
